Gelesis
is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of obesity and chronic diseases... Read moreGelesis
is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of obesity and chronic diseases... Read more
News
Oct 31, 2023
MarketScreener
Gelesis: Gelesis : Bankruptcy - Form 8-K
Jun 26, 2023
Business Wire
Press Release: Gelesis : Gelesis' Oral Treatment for Weight Management Showed Real-World Effectiveness in New Data Presented at the American Diabetes Association's Annual Conference
Mar 29, 2023
Owler
Gelesis, Inc.: Gelesis's employee count changed from 103 in Dec 2021 to 93 in Dec 2022
Mar 28, 2023
BioSpace
Gelesis: Gelesis Reports Fourth Quarter and Full Year 2022 Results
Mar 03, 2023
MarketScreener
Gelesis: Gelesis : Shareholder Director Nominations - Form 8-K
Jan 05, 2023
Business Wire
Press Release: Gelesis : Gelesis to Participate in the 25th Annual ICR Conference
Jan 04, 2023
Acrofan
Gelesis: NYSE to Suspend Trading Immediately in Warrants of Gelesis Holdings, Inc. (GLS WS) and Commence Delisting Proceedings
Nov 21, 2022
MarketScreener
Gelesis: Gelesis Reports Upcoming Participation in Wolfe Research's Annual Consumer Growth Conference
Nov 19, 2022
Life Care News
Gelesis: Gelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-Compliance
Nov 14, 2022
MarketScreener
Gelesis: Gelesis : Third Quarter 2022 Investor Presentation
Gelesis Competitors
1
2
3
4
5
6
7
8
9
10